Press Releases

PHILADELPHIA — (July 13, 2022) — The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious diseases, is pleased to announce the appointment of Gelvina Rodriguez Stevenson, Esq., as vice president, general counsel, secretary and government relations.

New synthetic nucleic acid approach seeks to use the body as the machinery for production of its own targeted protective antibodies.

World-wide reach of HIV cure initiative supports virtual event across countries.

PHILADELPHIA — (June 21, 2022) — Due to the development of resistance to chemotherapy and recurring tumors, patients with ovarian cancer often have low survival rates. Therefore, new therapeutic options such as targeted therapy that boosts anti-tumor immunity are needed to improve ovarian cancer treatment efficacy and patient survival. 

Campaign supports a 5-year plan to accelerate rapid-response to global health crises through focused centers of scientific discovery and life science education.